8-K: Acuren Corporation Announces NYSE Uplisting and First Quarter 2025 Results

Acuren Corporation reports a 5.0% revenue increase for Q1 2025, driven by organic growth, and announces its uplisting from NYSE American to the New York Stock Exchange.

Summary

• Acuren Corporation announced its Q1 2025 financial results, reporting a 5.0% increase in revenue to $234.2 million compared to $223.1 million in the prior year.
• The company experienced a net loss of $25.9 million, compared to a net loss of $1.3 million in the prior year, attributed to increased depreciation and amortization from the ASP Acuren Acquisition, a valuation allowance on a deferred tax asset, and planned public company and business transformation costs.
• Adjusted EBITDA was $25.9 million, with a margin of 11.0%, compared to $35.5 million and 15.9% respectively in the prior year.
• Acuren is reiterating its full-year 2025 revenue growth expectation to be in the low-to-mid-single digit percent range.
• The company also announced its uplisting to the New York Stock Exchange (NYSE) from the NYSE American, effective May 19, 2025, and will continue to trade under the symbol TIC.
• Acuren had total liquidity of $224.9 million as of March 31, 2025, including $155.7 million in cash and cash equivalents.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to revenue growth and the NYSE uplisting, but the increased net loss tempers the overall outlook.

Positives

• Revenue increased by 5.0% year-over-year, indicating growth in the business.
• The company had $224.9 million in total liquidity, including $155.7 million in cash and cash equivalents, providing financial flexibility.
• Acuren is uplisting to the NYSE, which is expected to increase visibility and attract a broader investor base.
• Organic growth was 7.2% highlighting the resilience of the recurring nature of revenues.

Negatives

• The company reported a net loss of $25.9 million, a significant increase from the $1.3 million loss in the prior year.
• Adjusted EBITDA margin decreased to 11.0% from 15.9% in the prior year.
• The net loss includes increased depreciation and amortization related to the ASP Acuren Acquisition, a valuation allowance on a deferred tax asset, and planned public company and business transformation costs.

Risks

• The company's forward-looking statements are subject to various risks and uncertainties, including economic conditions, customer investment, and competition.
• The company's revenues are primarily derived from short-term contracts, which could impact future revenue if contracts are not renewed.
• The company's substantial level of indebtedness could restrict operations.

Future Outlook

Acuren reiterates its full-year 2025 expectation for revenue growth to be in the low-to-mid-single digit percent range as compared to full year 2024.

Management Comments

• Tal Pizzey, CEO of Acuren, stated that they delivered 7.2% organic growth in the quarter, highlighting the resilience of the recurring nature of their revenues.
• Robert A.E. Franklin, Co-Chairman of Acuren, commented that Acuren's start to 2025 demonstrates the company's operational discipline and resilience.
• Tal Pizzey, CEO of Acuren, said that listing on the NYSE is a tremendous achievement for Acuren and a proud moment for their entire team.
• Robert A.E. Franklin, Co-Chairman of Acuren, commented that joining the NYSE marks yet another defining milestone for Acuren and underscores the Company's readiness to stand alongside larger, more liquid companies.

Industry Context

Acuren operates in the Testing, Inspection, Certification, and Compliance (TICC) sector, providing critical asset integrity services primarily in North America. The uplisting to the NYSE could position Acuren to compete more effectively with larger players in the industry and attract a broader investor base.

Comparison to Industry Standards

• Comparing Acuren's performance to companies like Intertek, SGS, and Bureau Veritas, which are global leaders in the TICC industry, Acuren's revenue growth of 5.0% is within a reasonable range, although the net loss is a concern.
• These larger companies often have more diversified service offerings and geographic presence, which can provide more stable financial performance.
• Acuren's focus on recurring maintenance needs of customers is a positive aspect, as it provides a more predictable revenue stream.

Stakeholder Impact

• Shareholders may benefit from increased visibility and liquidity due to the NYSE uplisting.
• Employees may see increased opportunities as the company grows and expands.
• Customers can expect continued service and support as Acuren focuses on recurring maintenance needs.

Next Steps

• Acuren will commence trading on the NYSE on May 19, 2025, under the ticker symbol TIC.
• The company will continue to focus on organic growth and pricing discipline.
• Acuren will continue to pursue value-enhancing initiatives while maintaining financial discipline.

Key Dates

Keywords

Acuren, NYSE, Uplisting, Financial Results, Revenue, EBITDA, Asset Integrity, Inspection, Testing, Certification, Compliance